• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Mary Bird Perkins Cancer Center to Partner With OneOncology


Mary Bird Perkins Cancer Center and OneOncology have signed an partnership agreement that will become effective this fall, the entities announced today. Once in place, this partnership will expand access to resources for cancer patients unlike any other approach in the Gulf South.

Mary Bird Perkins Cancer Center is an independent, community-owned nonprofit organization and leading Gulf South cancer care provider, serving patients throughout southeast Louisiana and southwest Mississippi for 50 years. With an exceptional track record of providing high-quality care, national leadership in clinical research, dedication to prevention and early detection, and value-based relationships, Mary Bird Perkins Cancer Center aligns with OneOncology’s focus on enhancing community-based cancer care.

“This is an exciting time for Mary Bird Perkins and the board is in support,” said board chairman at Mary Bird Perkins Cancer Center Art Favre. “OneOncology lines up with our founding principles established 50 years ago to focus exclusively on advancing cancer outcomes.”

OneOncology, the national platform for independent oncology practices, brings resources, access to a broad network of physicians across the country, information technology assets, and national buying power to Mary Bird Perkins. This partnership is anticipated to fuel program growth, reduce costs for patients, and expand access to clinical trials.

OneOncology has operationalized its approach to improve the lives of everyone living with cancer, including:

  • Physicians driving change and collaborating throughout its network
  • Bringing the brightest minds in oncology together
  • Powering an analytics platform that leverages clinical data to enhance operations and patient health outcomes

“Partnering with OneOncology is yet another milestone for Mary Bird Perkins as we recognize our 50 years of community-based cancer care,” said president and chief executive officer at Mary Bird Perkins Cancer Center Todd Stevens. “It’s a strategic move for the organization that supports our continued philosophy of focusing 100% on cancer. OneOncology and Mary Bird Perkins believe that focusing solely on the needs of individuals impacted by cancer by elevating doctor-patient relationships and bolstering technology, medicine and other key initiatives are critical in keeping pace with the rapid innovations in the field. We want to empower and involve physicians throughout the decision-making process because it leads to better outcomes.”

Joining Mary Bird Perkins in partnership with OneOncology are some the largest radiation and medical oncology groups that have worked with the Cancer Center for decades, including Southeastern Louisiana Radiation Oncology Group and Northshore Oncology Associates. Louisiana Hematology Oncology Associates, which serves the Greater Baton Rouge area, is expected to join the partnership in late 2021 or early 2022,

Through the remainder of 2021, Mary Bird Perkins Cancer Center and OneOncology will finalize plans and identify opportunities to optimize the partnership.

Related Videos
Ben Jones, McKesson/Us Oncology
Kathy Oubre, MS, Pontchartrain Cancer Center
Jonathan E. Levitt, Esq, Frier Levitt, LLC
Judy Alberto, MHA, RPh, BCOP, Community Oncology Alliance
Sandra Stein, MD
Dr Denise Holston
Emily Touloukian, DO, Coastal Cancer Center
Dr Padma Sripada, Columbia Internal Medicine
Joshua K. Sabari, MD, NYU Langone Perlmutter Cancer Center
Joshua K. Sabari, MD< NYU Langone Perlmutter Cancer Center
Related Content
© 2024 MJH Life Sciences
All rights reserved.